William Langston

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Chemicals & Drugs

Disorders

Anatomy

Living Beings

Concepts & Ideas

Magnetic Resonance Imaging

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Schüle Birgitt; Pera Renee A Reijo; Langston J William
Can cellular models revolutionize drug discovery in Parkinson's disease?
Tanner Caroline M; Ross G Webster; Jewell Sarah A; Hauser Robert A; Jankovic Joseph; Factor Stewart A; Bressman Susan; Deligtisch Amanda; Marras Connie; Lyons Kelly E; Bhudhikanok Grace S; Roucoux Diana F; Meng Cheryl; Abbott Robert D; Langston J William
Occupation and risk of parkinsonism: a multicenter case-control study.
Grimbergen Yvette A M; Langston J William; Roos Raymund A C; Bloem Bastiaan R
Postural instability in Parkinson's disease: the adrenergic hypothesis and the locus coeruleus.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of William Langston (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Schüle Birgitt; Pera Renee A Reijo; Langston J William
Can cellular models revolutionize drug discovery in Parkinson's disease?
Biochimica et biophysica acta 2009;1792(11):1043-51.
2009: Tanner Caroline M; Ross G Webster; Jewell Sarah A; Hauser Robert A; Jankovic Joseph; Factor Stewart A; Bressman Susan; Deligtisch Amanda; Marras Connie; Lyons Kelly E; Bhudhikanok Grace S; Roucoux Diana F; Meng Cheryl; Abbott Robert D; Langston J William
Occupation and risk of parkinsonism: a multicenter case-control study.
Archives of neurology 2009;66(9):1106-13.
2009: Grimbergen Yvette A M; Langston J William; Roos Raymund A C; Bloem Bastiaan R
Postural instability in Parkinson's disease: the adrenergic hypothesis and the locus coeruleus.
Expert review of neurotherapeutics 2009;9(2):279-90.
2009: Christine Chadwick W; Langston J William; Turner Robert S; Starr Philip A
The neurophysiology and effect of deep brain stimulation in a patient with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism.
Journal of neurosurgery 2009;110(2):234-8.
2009: Bronstein Jeff; Carvey Paul; Chen Honglei; Cory-Slechta Deborah; DiMonte Donato; Duda John; English Paul; Goldman Samuel; Grate Stephen; Hansen Johnni; Hoppin Jane; Jewell Sarah; Kamel Freya; Koroshetz Walter; Langston James W; Logroscino Giancarlo; Nelson Lorene; Ravina Bernard; Rocca Walter; Ross George W; Schettler Ted; Schwarzschild Michael; Scott Bill; Seegal Richard; Singleton Andrew; Steenland Kyle; Tanner Caroline M; Van Den Eeden Stephen; Weisskopf Marc
Meeting report: consensus statement-Parkinson's disease and the environment: collaborative on health and the environment and Parkinson's Action Network (CHE PAN) conference 26-28 June 2007.
Environmental health perspectives 2009;117(1):117-21.
2008: Ross Owen A; Braithwaite Adam T; Skipper Lisa M; Kachergus Jennifer; Hulihan Mary M; Middleton Frank A; Nishioka Kenya; Fuchs Julia; Gasser Thomas; Maraganore Demetrius M; Adler Charles H; Larvor Lydie; Chartier-Harlin Marie-Christine; Nilsson Christer; Langston J William; Gwinn Katrina; Hattori Nobutaka; Farrer Matthew J
Genomic investigation of alpha-synuclein multiplication and parkinsonism.
Annals of neurology 2008;63(6):743-50.
2008: Doostzadeh Julie; Shokralla Shadi; Absalan Farnaz; Jalili Roxana; Mohandessi Sharareh; Langston James W; Davis Ronald W; Ronaghi Mostafa; Gharizadeh Baback
High throughput automated allele frequency estimation by pyrosequencing.
PloS one 2008;3(7):e2693.
2007: Quik Maryka; Cox Heather; Parameswaran Neeraja; O'Leary Kathryn; Langston J William; Di Monte Donato
Nicotine reduces levodopa-induced dyskinesias in lesioned monkeys.
Annals of neurology 2007;62(6):588-96.
2007: Manning-Bog Amy B; Caudle W Michael; Perez Xiomara A; Reaney Stephen H; Paletzki Ronald; Isla Martha Z; Chou Vivian P; McCormack Alison L; Miller Gary W; Langston J William; Gerfen Charles R; Dimonte Donato A
Increased vulnerability of nigrostriatal terminals in DJ-1-deficient mice is mediated by the dopamine transporter.
Neurobiology of disease 2007;27(2):141-50.
2007: Doostzadeh J; Tetrud J W; Allen-Auerbach M; Langston J W; Schüle B
Novel features in a patient homozygous for the L347P mutation in the PINK1 gene.
Parkinsonism & related disorders 2007;13(6):359-61.
2007: Cox Heather; Togasaki Daniel M; Chen Li; Langston J William; Di Monte Donato A; Quik Maryka
The selective kappa-opioid receptor agonist U50,488 reduces L-dopa-induced dyskinesias but worsens parkinsonism in MPTP-treated primates.
Experimental neurology 2007;205(1):101-7.
2007: Manning-Bog Amy B; Langston J William
Model fusion, the next phase in developing animal models for Parkinson's disease.
Neurotoxicity research 2007;11(3-4):219-40.
2007: Fuchs J; Nilsson C; Kachergus J; Munz M; Larsson E-M; Schüle B; Langston J W; Middleton F A; Ross O A; Hulihan M; Gasser T; Farrer M J
Phenotypic variation in a large Swedish pedigree due to SNCA duplication and triplication.
Neurology 2007;68(12):916-22.
2007: Kamel F; Tanner Cm; Umbach Dm; Hoppin Ja; Alavanja McR; Blair A; Comyns K; Goldman Sm; Korell M; Langston Jw; Ross Gw; Sandler Dp
Pesticide exposure and self-reported Parkinson's disease in the agricultural health study.
American journal of epidemiology 2007;165(4):364-74.
2007: Langston J William; Tanner Caroline M; Schüle Birgitt
Parkin gene variations and parkinsonism: association does not imply causation.
Annals of neurology 2007;61(1):4-6.
2007: Doostzadeh Julie; Davis Ronald W; Giaever Guri N; Nislow Corey; Langston James W
Chemical genomic profiling for identifying intracellular targets of toxicants producing Parkinson's disease.
Toxicological sciences : an official journal of the Society of Toxicology 2007;95(1):182-7.
2006: Bordia Tanuja; Parameswaran Neeraja; Fan Hong; Langston J William; McIntosh J Michael; Quik Maryka
Partial recovery of striatal nicotinic receptors in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-lesioned monkeys with chronic oral nicotine.
The Journal of pharmacology and experimental therapeutics 2006;319(1):285-92.
2006: Quik Maryka; Parameswaran Neeraja; McCallum Sarah E; Bordia Tanuja; Bao Shanshan; McCormack Alison; Kim Amy; Tyndale Rachel F; Langston J William; Di Monte Donato A
Chronic oral nicotine treatment protects against striatal degeneration in MPTP-treated primates.
Journal of neurochemistry 2006;98(6):1866-75.
2006: Manning-Bog Amy B; Reaney Stephen H; Chou Vivian P; Johnston Louisa C; McCormack Alison L; Johnston Jennifer; Langston J William; Di Monte Donato A
Lack of nigrostriatal pathology in a rat model of proteasome inhibition.
Annals of neurology 2006;60(2):256-60.
2006: McCormack A L; Atienza J G; Langston J W; Di Monte D A
Decreased susceptibility to oxidative stress underlies the resistance of specific dopaminergic cell populations to paraquat-induced degeneration.
Neuroscience 2006;141(2):929-37.
2006: Goldman Samuel M; Tanner Caroline M; Oakes David; Bhudhikanok Grace S; Gupta Anjali; Langston J William
Head injury and Parkinson's disease risk in twins.
Annals of neurology 2006;60(1):65-72.
2006: Quik Maryka; Chen Li; Parameswaran Neeraja; Xie Xinmin; Langston J William; McCallum Sarah E
Chronic oral nicotine normalizes dopaminergic function and synaptic plasticity in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned primates.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2006;26(17):4681-9.
2006: Helton K J; Phillips N S; Khan R B; Boop F A; Sanford R A; Zou P; Li C S; Langston J W; Ogg R J
Diffusion tensor imaging of tract involvement in children with pontine tumors.
AJNR. American journal of neuroradiology 2006;27(4):786-93.
2006: Langston J William
The Parkinson's complex: parkinsonism is just the tip of the iceberg.
Annals of neurology 2006;59(4):591-6.
2006: Lang Anthony E; Langston J William; Stoessl A Jon; Brodsky Matthew; Brooks David J; Dhawan Vijay; Elias William J; Lozano Andres M; Moro Elena; Nutt John G; Stacy Mark; Turner Dennis; Wooten G Frederick
GDNF in treatment of Parkinson's disease: response to editorial.
Lancet neurology 2006;5(3):200-2.
2006: Sherer Todd B; Fiske Brian K; Svendsen Clive N; Lang Anthony E; Langston J William
Crossroads in GDNF therapy for Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 2006;21(2):136-41.
2006: McCallum Sarah E; Parameswaran Neeraja; Bordia Tanuja; Fan Hong; Tyndale Rachel F; Langston J William; McIntosh J Michael; Quik Maryka
Increases in alpha4* but not alpha3*/alpha6* nicotinic receptor sites and function in the primate striatum following chronic oral nicotine treatment.
Journal of neurochemistry 2006;96(4):1028-41.
2005: Goldman S M; Tanner C M; Olanow C W; Watts R L; Field R D; Langston J W
Occupation and parkinsonism in three movement disorders clinics.
Neurology 2005;65(9):1430-5.
2005: Reddick Wilburn E; Glass John O; Helton Kathleen J; Langston James W; Li Chin-Shang; Pui Ching-Hon
A quantitative MR imaging assessment of leukoencephalopathy in children treated for acute lymphoblastic leukemia without irradiation.
AJNR. American journal of neuroradiology 2005;26(9):2371-7.
2005: Togasaki Daniel M; Hsu Albert; Samant Meghana; Farzan Bijan; DeLanney Louis E; Langston J William; Di Monte Donato A; Quik Maryka
The Webcam system: a simple, automated, computer-based video system for quantitative measurement of movement in nonhuman primates.
Journal of neuroscience methods 2005;145(1-2):159-66.
2005: Marras Connie; Goldman Samuel; Smith Amanda; Barney Peter; Aston Diana; Comyns Kathleen; Korell Monica; Langston J William; Ross G Webster; Tanner Caroline M
Smell identification ability in twin pairs discordant for Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 2005;20(6):687-93.
2005: Reddick Wilburn E; Glass John O; Helton Kathleen J; Langston James W; Xiong Xiaoping; Wu Shengjie; Pui Ching-Hon
Prevalence of leukoencephalopathy in children treated for acute lymphoblastic leukemia with high-dose methotrexate.
AJNR. American journal of neuroradiology 2005;26(5):1263-9.
2005: Helton Kathleen J; Edwards Michael; Steen R Grant; Merchant Thomas E; Sapp Mark V; Boop Frederick A; Langston James
Neuroimaging-detected late transient treatment-induced lesions in pediatric patients with brain tumors.
Journal of neurosurgery 2005;102(2 Suppl):179-86.
2005: Togasaki Daniel M; Protell Peter; Tan Louis C S; Langston J William; Di Monte Donato A; Quik Maryka
Dyskinesias in normal squirrel monkeys induced by nomifensine and levodopa.
Neuropharmacology 2005;48(3):398-405.
2005: Reddick Wilburn E; Glass John O; Palmer Shawna L; Wu Shingjie; Gajjar Amar; Langston James W; Kun Larry E; Xiong Xiaoping; Mulhern Raymond K
Atypical white matter volume development in children following craniospinal irradiation.
Neuro-oncology 2005;7(1):12-9.
2005: Ravina B; Eidelberg D; Ahlskog J E; Albin R L; Brooks D J; Carbon M; Dhawan V; Feigin A; Fahn S; Guttman M; Gwinn-Hardy K; McFarland H; Innis R; Katz R G; Kieburtz K; Kish S J; Lange N; Langston J W; Marek K; Morin L; Moy C; Murphy D; Oertel W H; Oliver G; Palesch Y; Powers W; Seibyl J; Sethi K D; Shults C W; Sheehy P; Stoessl A J; Holloway R
The role of radiotracer imaging in Parkinson disease.
Neurology 2005;64(2):208-15.
2005: Langston J William
The promise of stem cells in Parkinson disease.
The Journal of clinical investigation 2005;115(1):23-5.
2005: Zou Ping; Mulhern Raymond K; Butler Robert W; Li Chin-Shang; Langston James W; Ogg Robert J
BOLD responses to visual stimulation in survivors of childhood cancer.
NeuroImage 2005;24(1):61-9.
2005: Chen L; Togasaki D M; Langston J W; Di Monte D A; Quik M
Enhanced striatal opioid receptor-mediated G-protein activation in L-DOPA-treated dyskinetic monkeys.
Neuroscience 2005;132(2):409-20.
2004: Fouladi Maryam; Chintagumpala Murali; Laningham Fred H; Ashley David; Kellie Stewart J; Langston James W; McCluggage Charles W; Woo Shaio; Kocak Mehmet; Krull Kevin; Kun Larry E; Mulhern Raymond K; Gajjar Amar
White matter lesions detected by magnetic resonance imaging after radiotherapy and high-dose chemotherapy in children with medulloblastoma or primitive neuroectodermal tumor.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(22):4551-60.
2004: Hsu Albert; Togasaki Daniel M; Bezard Erwan; Sokoloff Pierre; Langston J William; Di Monte Donato A; Quik Maryka
Effect of the D3 dopamine receptor partial agonist BP897 [N-[4-(4-(2-methoxyphenyl)piperazinyl)butyl]-2-naphthamide] on L-3,4-dihydroxyphenylalanine-induced dyskinesias and parkinsonism in squirrel monkeys.
The Journal of pharmacology and experimental therapeutics 2004;311(2):770-7.
2004: Olanow C W; Kieburtz K; Stern M; Watts R; Langston J W; Guarnieri M; Hubble J;
Double-blind, placebo-controlled study of entacapone in levodopa-treated patients with stable Parkinson disease.
Archives of neurology 2004;61(10):1563-8.
2004: Hardy John; Langston J William
How many pathways are there to nigral death?
Annals of neurology 2004;56(3):316-8.
2004: Svendsen Clive N; Langston J William
Stem cells for Parkinson disease and ALS: replacement or protection?
Nature medicine 2004;10(3):224-5.
2004: Farrer Matt; Kachergus Jennifer; Forno Lysia; Lincoln Sarah; Wang Deng-Shun; Hulihan Mary; Maraganore Demetrius; Gwinn-Hardy Katrina; Wszolek Zbigniew; Dickson Dennis; Langston J William
Comparison of kindreds with parkinsonism and alpha-synuclein genomic multiplications.
Annals of neurology 2004;55(2):174-9.
2003: Steen R Grant; Xiong Xiaoping; Langston James W; Helton Kathleen J
Brain injury in children with sickle cell disease: prevalence and etiology.
Annals of neurology 2003;54(5):564-72.
2003: Thiffault Christine; Langston J William; Di Monte Donato A
Cerebrospinal fluid 3,4-dihydroxyphenylacetic acid level after tolcapone administration as an indicator of nigrostriatal degeneration.
Experimental neurology 2003;183(1):173-9.
2003: Tan Louis C; Tanner Caroline M; Chen Rong; Chan Piu; Farrer Matthew; Hardy John; Langston J William
Marked variation in clinical presentation and age of onset in a family with a heterozygous parkin mutation.
Movement disorders : official journal of the Movement Disorder Society 2003;18(7):758-63.
2003: Steen R Grant; Hankins Gisele M; Xiong Xiaoping; Wang Winfred C; Beil Kenneth; Langston James W; Helton Kathleen J
Prospective brain imaging evaluation of children with sickle cell trait: initial observations.
Radiology 2003;228(1):208-15.
2003: Chen R; Gosavi N S; Langston J W; Chan P
Parkin mutations are rare in patients with young-onset parkinsonism in a US population.
Parkinsonism & related disorders 2003;9(5):309-12.
2003: Lincoln S; Wiley J; Lynch T; Langston J W; Chen R; Lang A; Rogaeva E; Sa D S; Munhoz R P; Harris J; Marder K; Klein C; Bisceglio G; Hussey J; West A; Hulihan M; Hardy J; Farrer M
Parkin-proven disease: common founders but divergent phenotypes.
Neurology 2003;60(10):1605-10.
2003: Rodriguez-Galindo Carlos; Wilson Matthew W; Haik Barrett G; Merchant Thomas E; Billups Catherine A; Shah Nirali; Cain Alvida; Langston James; Lipson Mindy; Kun Larry E; Pratt Charles B
Treatment of intraocular retinoblastoma with vincristine and carboplatin.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(10):2019-25.
2003: Fouladi Maryam; Wallace Dana; Langston James W; Mulhern Raymond; Rose Susan R; Gajjar Amar; Sanford Robert A; Merchant Thomas E; Jenkins Jesse J; Kun Larry E; Heideman Richard L
Survival and functional outcome of children with hypothalamic/chiasmatic tumors.
Cancer 2003;97(4):1084-92.
2002: Chen Rong; Langston J William; Chan Piu
Screening of ferritin light polypeptide 460-461InsA mutation in Parkinson's disease patients in North America.
Neuroscience letters 2002;335(2):144-6.
2002: Langston J William
Parkinson's disease: current and future challenges.
Neurotoxicology 2002;23(4-5):443-50.
2002: Bolin Laurel M; Strycharska-Orczyk Iwona; Murray Richard; Langston J William; Di Monte Donato
Increased vulnerability of dopaminergic neurons in MPTP-lesioned interleukin-6 deficient mice.
Journal of neurochemistry 2002;83(1):167-75.
2002: Tan Louis C; Protell Peter H; Langston J William; Togasaki Daniel M
The hyperkinetic abnormal movements scale: a tool for measuring levodopa-induced abnormal movements in squirrel monkeys.
Movement disorders : official journal of the Movement Disorder Society 2002;17(5):902-9.
2002: Helton Kathleen J; Gajjar Amar; Hill D Ashley; Boop Frederick A; Kun Larry E; Langston James W
Medulloblastoma metastatic to the suprasellar region at diagnosis: a report of six cases with clinicopathologic correlation.
Pediatric neurosurgery 2002;37(3):111-7.
2002: McCormack Alison L; Thiruchelvam Mona; Manning-Bog Amy B; Thiffault Christine; Langston J William; Cory-Slechta Deborah A; Di Monte Donato A
Environmental risk factors and Parkinson's disease: selective degeneration of nigral dopaminergic neurons caused by the herbicide paraquat.
Neurobiology of disease 2002;10(2):119-27.
2002: Forno Lysia S; Langston J William; Herrick Maie K; Wilson Jon D; Murayama Shigeo
Ubiquitin-positive neuronal and tau 2-positive glial inclusions in frontotemporal dementia of motor neuron type.
Acta neuropathologica 2002;103(6):599-606.
2002: Yee Randa E; Huang Sung-Chen; Togasaki Daniel M; Langston J William; Satyamurthy N; Barrio Jorge R
Imaging and therapeutics: the role of neuronal transport in the regional specificity of L-DOPA accumulation in brain.
Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging 2002;4(3):208-18.
2002: Shoulson Ira; Oakes David; Fahn Stanley; Lang Anthony; Langston J William; LeWitt Peter; Olanow C Warren; Penney John B; Tanner Caroline; Kieburtz Karl; Rudolph Alice;
Impact of sustained deprenyl (selegiline) in levodopa-treated Parkinson's disease: a randomized placebo-controlled extension of the deprenyl and tocopherol antioxidative therapy of parkinsonism trial.
Annals of neurology 2002;51(5):604-12.
2002: Woulfe J M; Duke R; Middeldorp J M; Stevens S; Vervoort M; Hashimoto M; Masliah E; Chan P; Di Monte D A; Langston J W; Petzinger G; Hoogendoorn H; Munoz D G
Absence of elevated anti-alpha-synuclein and anti-EBV latent membrane protein antibodies in PD.
Neurology 2002;58(9):1435-6.
2002: Schlossmacher Michael G; Frosch Matthew P; Gai Wei Ping; Medina Miguel; Sharma Nutan; Forno Lysia; Ochiishi Tomoyo; Shimura Hideki; Sharon Ronit; Hattori Nobutaka; Langston J William; Mizuno Yoshikuni; Hyman Bradley T; Selkoe Dennis J; Kosik Kenneth S
Parkin localizes to the Lewy bodies of Parkinson disease and dementia with Lewy bodies.
The American journal of pathology 2002;160(5):1655-67.
2002: Reddick Wilburn E; Glass John O; Langston James W; Helton Kathleen J
Quantitative MRI assessment of leukoencephalopathy.
Magnetic resonance in medicine : official journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine 2002;47(5):912-20.
2002: Burkhard Pierre R; Langston J William; Tetrud James W
Voluntarily simulated tremor in normal subjects.
Neurophysiologie clinique = Clinical neurophysiology 2002;32(2):119-26.
2002: Tanner C M; Goldman S M; Aston D A; Ottman R; Ellenberg J; Mayeux R; Langston J W
Smoking and Parkinson's disease in twins.
Neurology 2002;58(4):581-8.
2002: Quik M; Police S; Langston J W; Di Monte D A
Increases in striatal preproenkephalin gene expression are associated with nigrostriatal damage but not L-DOPA-induced dyskinesias in the squirrel monkey.
Neuroscience 2002;113(1):213-20.
2001: Forno L; Langston J W
Clinical and neuropathological features: session III summary and research needs.
Neurotoxicology 2001;22(6):833-5.
2001: Tanner C M; Goldman S M; Lyons K E; Aston D A; Tetrud J W; Welsh M D; Langston J W; Koller W C
Essential tremor in twins: an assessment of genetic vs environmental determinants of etiology.
Neurology 2001;57(8):1389-91.
2001: Yee R E; Irwin I; Milonas C; Stout D B; Huang S C; Shoghi-Jadid K; Satyamurthy N; Delanney L E; Togasaki D M; Farahani K F; Delfani K; Janson A M; Phelps M E; Langston J W; Barrio J R
Novel observations with FDOPA-PET imaging after early nigrostriatal damage.
Movement disorders : official journal of the Movement Disorder Society 2001;16(5):838-48.
2001: Farrer M; Chan P; Chen R; Tan L; Lincoln S; Hernandez D; Forno L; Gwinn-Hardy K; Petrucelli L; Hussey J; Singleton A; Tanner C; Hardy J; Langston J W
Lewy bodies and parkinsonism in families with parkin mutations.
Annals of neurology 2001;50(3):293-300.
2001: Togasaki D M; Tan L; Protell P; Di Monte D A; Quik M; Langston J W
Levodopa induces dyskinesias in normal squirrel monkeys.
Annals of neurology 2001;50(2):254-7.
2001: Fouladi M; Jenkins J; Burger P; Langston J; Merchant T; Heideman R; Thompson S; Sanford A; Kun L; Gajjar A
Pleomorphic xanthoastrocytoma: favorable outcome after complete surgical resection.
Neuro-oncology 2001;3(3):184-92.
2001: Steen R G; Taylor J S; Langston J W; Glass J O; Brewer V R; Reddick W E; Mages R; Pivnick E K
Prospective evaluation of the brain in asymptomatic children with neurofibromatosis type 1: relationship of macrocephaly to T1 relaxation changes and structural brain abnormalities.
AJNR. American journal of neuroradiology 2001;22(5):810-7.
2001: Petzinger G M; Quik M; Ivashina E; Jakowec M W; Jakubiak M; Di Monte D; Langston J W
Reliability and validity of a new global dyskinesia rating scale in the MPTP-lesioned non-human primate.
Movement disorders : official journal of the Movement Disorder Society 2001;16(2):202-7.
2001: Mulhern R K; Palmer S L; Reddick W E; Glass J O; Kun L E; Taylor J; Langston J; Gajjar A
Risks of young age for selected neurocognitive deficits in medulloblastoma are associated with white matter loss.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(2):472-9.
2000: Langston J W; Tanner C M
Selegiline and Parkinson's disease: it's déjà vu-again.
Neurology 2000;55(12):1770-1.
2000: He L; Di Monte D A; Langston J W; Quik M
Autoradiographic analysis of dopamine receptor-stimulated [(35)S]GTPgammaS binding in rat striatum.
Brain research 2000;885(1):133-6.
2000: Thiffault C; Langston J W; Di Monte D A
Increased striatal dopamine turnover following acute administration of rotenone to mice.
Brain research 2000;885(2):283-8.
2000: Mahoney D H; Cohen M E; Friedman H S; Kepner J L; Gemer L; Langston J W; James H E; Duffner P K; Kun L E
Carboplatin is effective therapy for young children with progressive optic pathway tumors: a Pediatric Oncology Group phase II study.
Neuro-oncology 2000;2(4):213-20.
2000: Langston J W; Tan L C
Juvenile parkinsonism: a term in search of an identity.
European journal of neurology : the official journal of the European Federation of Neurological Societies 2000;7(5):465-6.
2000: Reddick W E; Russell J M; Glass J O; Xiong X; Mulhern R K; Langston J W; Merchant T E; Kun L E; Gajjar A
Subtle white matter volume differences in children treated for medulloblastoma with conventional or reduced dose craniospinal irradiation.
Magnetic resonance imaging 2000;18(7):787-93.
2000: Quik M; Polonskaya Y; Gillespie A; Jakowec M; Lloyd G K; Langston J W
Localization of nicotinic receptor subunit mRNAs in monkey brain by in situ hybridization.
The Journal of comparative neurology 2000;425(1):58-69.
2000: Kaste S C; Jenkins J J; Pratt C B; Langston J W; Haik B G
Retinoblastoma: sonographic findings with pathologic correlation in pediatric patients.
AJR. American journal of roentgenology 2000;175(2):495-501.
2000: McGrew D M; Irwin I; Langston J W
Ethylenebisdithiocarbamate enhances MPTP-induced striatal dopamine depletion in mice.
Neurotoxicology 2000;21(3):309-12.
2000: Walter A W; Gajjar A; Reardon D A; Thompson S J; Langston J W; Jones-Wallace D; Kun L E; Heideman R L
Tamoxifen and carboplatin for children with low-grade gliomas: a pilot study at St. Jude Children's Research Hospital.
Journal of pediatric hematology/oncology : official journal of the American Society of Pediatric Hematology/Oncology 2000;22(3):247-51.
2000: Langston J W; Quik M; Petzinger G; Jakowec M; Di Monte D A
Investigating levodopa-induced dyskinesias in the parkinsonian primate.
Annals of neurology 2000;47(4 Suppl 1):S79-89.
2000: Yee R E; Huang S C; Stout D B; Irwin I; Shoghi-Jadid K; Togaski D M; DeLanney L E; Langston J W; Satyamurthy N; Farahani K F; Phelps M E; Barrio J R
Nigrostriatal reduction of aromatic L-amino acid decarboxylase activity in MPTP-treated squirrel monkeys: in vivo and in vitro investigations.
Journal of neurochemistry 2000;74(3):1147-57.
2000: Snow B J; Vingerhoets F J; Langston J W; Tetrud J W; Sossi V; Calne D B
Pattern of dopaminergic loss in the striatum of humans with MPTP induced parkinsonism.
Journal of neurology, neurosurgery, and psychiatry 2000;68(3):313-6.
2000: Fouladi M; Langston J; Mulhern R; Jones D; Xiong X; Yang J; Thompson S; Walter A; Heideman R; Kun L; Gajjar A
Silent lacunar lesions detected by magnetic resonance imaging of children with brain tumors: a late sequela of therapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(4):824-31.
2000: Quik M; Polonskaya Y; Gillespie A; K Lloyd G; Langston J W
Differential alterations in nicotinic receptor alpha6 and beta3 subunit messenger RNAs in monkey substantia nigra after nigrostriatal degeneration.
Neuroscience 2000;100(1):63-72.
2000: He L; Di Monte D A; Langston J W; Quik M
Autoradiographic analysis of N-methyl-D-aspartate receptor binding in monkey brain: effects of 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine and levodopa treatment.
Neuroscience 2000;99(4):697-704.
2000: Quik M; Police S; He L; Di Monte D A; Langston J W
Expression of D(3) receptor messenger RNA and binding sites in monkey striatum and substantia nigra after nigrostriatal degeneration: effect of levodopa treatment.
Neuroscience 2000;98(2):263-73.
1999: Mulhern R K; Reddick W E; Palmer S L; Glass J O; Elkin T D; Kun L E; Taylor J; Langston J; Gajjar A
Neurocognitive deficits in medulloblastoma survivors and white matter loss.
Annals of neurology 1999;46(6):834-41.
1999: Markopoulou K; Langston J W
Candidate genes and Parkinson's disease: where to next?
Neurology 1999;53(7):1382-3.
1999: Langston J W; Forno L S; Tetrud J; Reeves A G; Kaplan J A; Karluk D
Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure.
Annals of neurology 1999;46(4):598-605.
1999: Fouladi M; Gajjar A; Boyett J M; Walter A W; Thompson S J; Merchant T E; Jenkins J J; Langston J W; Liu A; Kun L E; Heideman R L
Comparison of CSF cytology and spinal magnetic resonance imaging in the detection of leptomeningeal disease in pediatric medulloblastoma or primitive neuroectodermal tumor.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(10):3234-7.
1999: Ogg R J; Langston J W; Haacke E M; Steen R G; Taylor J S
The correlation between phase shifts in gradient-echo MR images and regional brain iron concentration.
Magnetic resonance imaging 1999;17(8):1141-8.
1999: Chow E; Jenkins J J; Burger P C; Reardon D A; Langston J W; Sanford R A; Heideman R L; Kun L E; Merchant T E
Malignant evolution of choroid plexus papilloma.
Pediatric neurosurgery 1999;31(3):127-30.
1999: Parasuraman S; Langston J; Rao B N; Poquette C A; Jenkins J J; Merchant T; Cain A; Pratt C B; Pappo A S
Brain metastases in pediatric Ewing sarcoma and rhabdomyosarcoma: the St. Jude Children's Research Hospital experience.
Journal of pediatric hematology/oncology : official journal of the American Society of Pediatric Hematology/Oncology 1999;21(5):370-7.
1999: Burkhard P R; Shale H; Langston J W; Tetrud J W
Quantification of dyskinesia in Parkinson's disease: validation of a novel instrumental method.
Movement disorders : official journal of the Movement Disorder Society 1999;14(5):754-63.
1999: Fouladi M; Heideman R; Langston J W; Kun L E; Thompson S J; Gajjar A
Infectious meningitis mimicking recurrent medulloblastoma on magnetic resonance imaging. Case report.
Journal of neurosurgery 1999;91(3):499-502.
1999: Royland J E; Delfani K; Langston J W; Janson A M; Di Monte D A
7-Nitroindazole prevents 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine-induced ATP loss in the mouse striatum.
Brain research 1999;839(1):41-8.
1999: Di Monte D A; Tokar I; Langston J W
Impaired glutamate clearance as a consequence of energy failure caused by MPP(+) in astrocytic cultures.
Toxicology and applied pharmacology 1999;158(3):296-302.
1999: Chow E; Reardon D A; Shah A B; Jenkins J J; Langston J; Heideman R L; Sanford R A; Kun L E; Merchant T E
Pediatric choroid plexus neoplasms.
International journal of radiation oncology, biology, physics 1999;44(2):249-54.
1999: Kadota R P; Kun L E; Langston J W; Burger P C; Cohen M E; Mahoney D H; Walter A W; Rodman J H; Parent A; Buckley E; Kepner J L; Friedman H S
Cyclophosphamide for the treatment of progressive low-grade astrocytoma: a Pediatric Oncology Group phase II Study.
Journal of pediatric hematology/oncology : official journal of the American Society of Pediatric Hematology/Oncology 1999;21(3):198-202.
1999: Steen R G; Langston J W; Ogg R J; Xiong X; Ye Z; Wang W C
Diffuse T1 reduction in gray matter of sickle cell disease patients: evidence of selective vulnerability to damage?
Magnetic resonance imaging 1999;17(4):503-15.
1999: Walters T L; Irwin I; Delfani K; Langston J W; Janson A M
Diethyldithiocarbamate causes nigral cell loss and dopamine depletion with nontoxic doses of MPTP.
Experimental neurology 1999;156(1):62-70.
1999: Steen R G; Xiong X; Mulhern R K; Langston J W; Wang W C
Subtle brain abnormalities in children with sickle cell disease: relationship to blood hematocrit.
Annals of neurology 1999;45(3):279-86.
1999: Steen R G; Reddick W E; Ogg R J; Langston J W
Effect of a gadodiamide contrast agent on the reliability of brain tissue T1 measurements.
Magnetic resonance imaging 1999;17(2):229-35.
1999: Tanner C M; Ottman R; Goldman S M; Ellenberg J; Chan P; Mayeux R; Langston J W
Parkinson disease in twins: an etiologic study.
JAMA : the journal of the American Medical Association 1999;281(4):341-6.
1998: Langston J W; Sastry S; Chan P; Forno L S; Bolin L M; Di Monte D A
Novel alpha-synuclein-immunoreactive proteins in brain samples from the Contursi kindred, Parkinson's, and Alzheimer's disease.
Experimental neurology 1998;154(2):684-90.
1998: Taylor J S; Ogg R J; Langston J W
Proton MR spectroscopy of pediatric brain tumors.
Neuroimaging clinics of North America 1998;8(4):753-79.
1998: Langston J W
Epidemiology versus genetics in Parkinson's disease: progress in resolving an age-old debate.
Annals of neurology 1998;44(3 Suppl 1):S45-52.
1998: Jakowec M W; Petzinger G M; Sastry S; Donaldson D M; McCormack A; Langston J W
The native form of alpha-synuclein is not found in the cerebrospinal fluid of patients with Parkinson's disease or normal controls.
Neuroscience letters 1998;253(1):13-6.
1998: Reardon D A; Gajjar A; Sanford R A; Heideman R L; Walter A W; Thompson S J; Merchant T E; Li H; Jenkins J J; Langston J; Boyett J M; Kun L E
Bithalamic involvement predicts poor outcome among children with thalamic glial tumors.
Pediatric neurosurgery 1998;29(1):29-35.
1998: Wang W C; Langston J W; Steen R G; Wynn L W; Mulhern R K; Wilimas J A; Kim F M; Figueroa R E
Abnormalities of the central nervous system in very young children with sickle cell anemia.
The Journal of pediatrics 1998;132(6):994-8.
1998: Reddick W E; Mulhern R K; Elkin T D; Glass J O; Merchant T E; Langston J W
A hybrid neural network analysis of subtle brain volume differences in children surviving brain tumors.
Magnetic resonance imaging 1998;16(4):413-21.
1998: Steen R G; Reddick W E; Mulhern R K; Langston J W; Ogg R J; Bieberich A A; Kingsley P B; Wang W C
Quantitative MRI of the brain in children with sickle cell disease reveals abnormalities unseen by conventional MRI.
Journal of magnetic resonance imaging : JMRI 1998;8(3):535-43.
1998: Rudoltz M S; Regine W F; Langston J W; Sanford R A; Kovnar E H; Kun L E
Multiple causes of cerebrovascular events in children with tumors of the parasellar region.
Journal of neuro-oncology 1998;37(3):251-61.
1998: Chan P; Jiang X; Forno L S; Di Monte D A; Tanner C M; Langston J W
Absence of mutations in the coding region of the alpha-synuclein gene in pathologically proven Parkinson's disease.
Neurology 1998;50(4):1136-7.
1998: Gronemeyer S A; Langston J W; Abraham J
Curved reconstruction along the anterior optic pathway.
AJNR. American journal of neuroradiology 1998;19(2):338-40.
1998: Chan P; Tanner C M; Jiang X; Langston J W
Failure to find the alpha-synuclein gene missense mutation (G209A) in 100 patients with younger onset Parkinson's disease.
Neurology 1998;50(2):513-4.
1998: Walter A W; Gajjar A; Ochs J S; Langston J W; Sanford R A; Kun L E; Heideman R
Carboplatin and etoposide with hyperfractionated radiotherapy in children with newly diagnosed diffuse pontine gliomas: a phase I/II study.
Medical and pediatric oncology 1998;30(1):28-33.
1998: Jakowec M W; Jackson-Lewis V; Chen X; Langston J W; Przedborski S
The postnatal development of AMPA receptor subunits in the basal ganglia of the rat.
Developmental neuroscience 1998;20(1):19-33.
1997: Di Monte D A; Royland J E; Anderson A; Castagnoli K; Castagnoli N; Langston J W
Inhibition of monoamine oxidase contributes to the protective effect of 7-nitroindazole against MPTP neurotoxicity.
Journal of neurochemistry 1997;69(4):1771-3.
1997: Gajjar A; Sanford R A; Heideman R; Jenkins J J; Walter A; Li Y; Langston J W; Muhlbauer M; Boyett J M; Kun L E
Low-grade astrocytoma: a decade of experience at St. Jude Children's Research Hospital.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(8):2792-9.
1997: Irwin I; Delanney L; Chan P; Sandy M S; Di Monte D A; Langston J W
Nigrostriatal monoamine oxidase A and B in aging squirrel monkeys and C57BL/6 mice.
Neurobiology of aging 1997;18(2):235-41.
1997: Broniscer A; Gajjar A; Bhargava R; Langston J W; Heideman R; Jones D; Kun L E; Taylor J
Brain stem involvement in children with neurofibromatosis type 1: role of magnetic resonance imaging and spectroscopy in the distinction from diffuse pontine glioma.
Neurosurgery 1997;40(2):331-7; discussion 337-8.
1997: Chan P; Di Monte D A; Langston J W; Janson A M
(+)MK-801 does not prevent MPTP-induced loss of nigral neurons in mice.
The Journal of pharmacology and experimental therapeutics 1997;280(1):439-46.
1996: Olanow C W; Fahn S; Langston J W; Godbold J
Selegiline and mortality in Parkinson's disease.
Annals of neurology 1996;40(6):841-5.
1996: Taylor J S; Langston J W; Reddick W E; Kingsley P B; Ogg R J; Pui M H; Kun L E; Jenkins J J; Chen G; Ochs J J; Sanford R A; Heideman R L
Clinical value of proton magnetic resonance spectroscopy for differentiating recurrent or residual brain tumor from delayed cerebral necrosis.
International journal of radiation oncology, biology, physics 1996;36(5):1251-61.
1996: Langston J W
The etiology of Parkinson's disease with emphasis on the MPTP story.
Neurology 1996;47(6 Suppl 3):S153-60.
1996: Di Monte D A; Royland J E; Jakowec M W; Langston J W
Role of nitric oxide in methamphetamine neurotoxicity: protection by 7-nitroindazole, an inhibitor of neuronal nitric oxide synthase.
Journal of neurochemistry 1996;67(6):2443-50.
1996: Gajjar A; Sanford R A; Bhargava R; Heideman R; Walter A; Li Y; Langston J W; Jenkins J J; Muhlbauer M; Boyett J; Kun L E
Medulloblastoma with brain stem involvement: the impact of gross total resection on outcome.
Pediatric neurosurgery 1996;25(4):182-7.
1996: Di Monte D A; DeLanney L E; Irwin I; Royland J E; Chan P; Jakowec M W; Langston J W
Monoamine oxidase-dependent metabolism of dopamine in the striatum and substantia nigra of L-DOPA-treated monkeys.
Brain research 1996;738(1):53-9.
1996: Sandy M S; Armstrong M; Tanner C M; Daly A K; Di Monte D A; Langston J W; Idle J R
CYP2D6 allelic frequencies in young-onset Parkinson's disease.
Neurology 1996;47(1):225-30.
1996: Beck K D; Irwin I; Valverde J; Brennan T J; Langston J W; Hefti F
GDNF induces a dystonia-like state in neonatal rats and stimulates dopamine and serotonin synthesis.
Neuron 1996;16(3):665-73.
1996: Steen R G; Langston J W; Reddick W E; Ogg R; Chen G; Wang W C
Quantitative MR imaging of children with sickle cell disease: striking T1 elevation in the thalamus.
Journal of magnetic resonance imaging : JMRI 1996;6(1):226-34.
1996: Di Monte D A; Royland J E; Irwin I; Langston J W
Astrocytes as the site for bioactivation of neurotoxins.
Neurotoxicology 1996;17(3-4):697-703.
1996: Forno L S; DeLanney L E; Irwin I; Langston J W
Electron microscopy of Lewy bodies in the amygdala-parahippocampal region. Comparison with inclusion bodies in the MPTP-treated squirrel monkey.
Advances in neurology 1996;69():217-28.
1995: Di Monte D A; Schipper H M; Hetts S; Langston J W
Iron-mediated bioactivation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in glial cultures.
Glia 1995;15(2):203-6.
1995: Bloem B R; Beckley D J; van Vugt J P; van Dijk J G; Remler M P; Langston J W; Roos R A
Long latency postural reflexes are under supraspinal dopaminergic control.
Movement disorders : official journal of the Movement Disorder Society 1995;10(5):580-8.
1995: Gajjar A; Bhargava R; Jenkins J J; Heideman R; Sanford R A; Langston J W; Walter A W; Kuttesch J F; Muhlbauer M; Kun L E
Low-grade astrocytoma with neuraxis dissemination at diagnosis.
Journal of neurosurgery 1995;83(1):67-71.
1995: Finnegan K T; Irwin I; Delanney L E; Langston J W
Age-dependent effects of the 2'-methyl analog of 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine: prevention by inhibitors of monoamine oxidase B.
The Journal of pharmacology and experimental therapeutics 1995;273(2):716-20.
1995: Forno L S; DeLanney L E; Irwin I; Langston J W
Ultrastructure of eosinophilic inclusion bodies in the amygdala-parahippocampal region of aged squirrel monkeys treated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, a dopaminergic neurotoxin.
Neuroscience letters 1995;184(1):44-7.
1994: Irwin I; DeLanney L E; McNeill T; Chan P; Forno L S; Murphy G M; Di Monte D A; Sandy M S; Langston J W
Aging and the nigrostriatal dopamine system: a non-human primate study.
Neurodegeneration : a journal for neurodegenerative disorders, neuroprotection, and neuroregeneration 1994;3(4):251-65.
1994: Vingerhoets F J; Snow B J; Tetrud J W; Langston J W; Schulzer M; Calne D B
Positron emission tomographic evidence for progression of human MPTP-induced dopaminergic lesions.
Annals of neurology 1994;36(5):765-70.
1994: Forno L S; DeLanney L E; Irwin I; Langston J W
Evolution of nerve fiber degeneration in the striatum in the MPTP-treated squirrel monkey.
Molecular neurobiology 1994;9(1-3):163-70.
1994: Tetrud J W; Langston J W; Irwin I; Snow B
Parkinsonism caused by petroleum waste ingestion.
Neurology 1994;44(6):1051-4.
1994: Chan P; Di Monte D A; Luo J J; DeLanney L E; Irwin I; Langston J W
Rapid ATP loss caused by methamphetamine in the mouse striatum: relationship between energy impairment and dopaminergic neurotoxicity.
Journal of neurochemistry 1994;62(6):2484-7.
1994: Chan P; Di Monte D A; Langston J W
Effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on levels of glutamate and aspartate in the mouse brain.
Brain research 1994;647(2):249-54.
1994: Bloem B R; Beckley D J; van Dijk J G; Zwinderman A H; Remler M P; Langston J W; Roos R A
Medium latency stretch reflexes in young-onset Parkinson's disease and MPTP-induced parkinsonism.
Journal of the neurological sciences 1994;123(1-2):52-8.
1994: Reddick W E; Langston J W; Meyer W H; Gronemeyer S A; Steen R G; Chen G; Taylor J S
Discrete signal processing of dynamic contrast-enhanced MR imaging: statistical validation and preliminary clinical application.
Journal of magnetic resonance imaging : JMRI 1994;4(3):397-404.
1994: Pratt C B; Fontanesi J; Chenaille P; Kun L E; Jenkins J J; Langston J W; Mounce K G; Meyer D
Chemotherapy for extraocular retinoblastoma.
Pediatric hematology and oncology 1994;11(3):301-9.
1994: Di Monte D A; Harati Y; Jankovic J; Sandy M S; Jewell S A; Langston J W
Muscle mitochondrial ATP production in progressive supranuclear palsy.
Journal of neurochemistry 1994;62(4):1631-4.
1994: Pui M H; Fletcher B D; Langston J W
Granulocytic sarcoma in childhood leukemia: imaging features.
Radiology 1994;190(3):698-702.
1993: Chan P; Langston J W; Di Monte D A
MK-801 temporarily prevents MPTP-induced acute dopamine depletion and MPP+ elimination in the mouse striatum.
The Journal of pharmacology and experimental therapeutics 1993;267(3):1515-20.
1993: Pui M H; Langston J W; Arai Y
Gd-DTPA enhancement of CSF in meningeal carcinomatosis.
Journal of computer assisted tomography 1993;17(6):940-4.
1993: Kurth M C; Tetrud J W; Tanner C M; Irwin I; Stebbins G T; Goetz C G; Langston J W
Double-blind, placebo-controlled, crossover study of duodenal infusion of levodopa/carbidopa in Parkinson's disease patients with 'on-off' fluctuations.
Neurology 1993;43(9):1698-703.
1993: Chan P; Langston J W; Irwin I; DeLanney L E; Di Monte D A
2-deoxyglucose enhances 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced ATP loss in the mouse brain.
Journal of neurochemistry 1993;61(2):610-6.
1993: Kurth M C; Tetrud J W; Irwin I; Lyness W H; Langston J W
Oral levodopa/carbidopa solution versus tablets in Parkinson's patients with severe fluctuations: a pilot study.
Neurology 1993;43(5):1036-9.
1993: Lapchak P A; Beck K D; Araujo D M; Irwin I; Langston J W; Hefti F
Chronic intranigral administration of brain-derived neurotrophic factor produces striatal dopaminergic hypofunction in unlesioned adult rats and fails to attenuate the decline of striatal dopaminergic function following medial forebrain bundle transection.
Neuroscience 1993;53(3):639-50.
1993: Hanna S L; Langston J W; Parham D M; Douglass E C
Primary malignant rhabdoid tumor of the brain: clinical, imaging, and pathologic findings.
AJNR. American journal of neuroradiology 1993;14(1):107-15.
1993: Widner H; Tetrud J; Rehncrona S; Snow B J; Brundin P; Björklund A; Lindvall O; Langston J W
Fifteen months' follow-up on bilateral embryonic mesencephalic grafts in two cases of severe MPTP-induced parkinsonism.
Advances in neurology 1993;60():729-33.
1993: Graybiel A M; Moratalla R; Quinn B; DeLanney L E; Irwin I; Langston J W
Early-stage loss of dopamine uptake-site binding in MPTP-treated monkeys.
Advances in neurology 1993;60():34-9.
1993: Irwin I; DeLanney L E; Langston J W
MPTP and aging. Studies in the C57BL/6 mouse.
Advances in neurology 1993;60():197-206.
1993: Sandy M S; Langston J W; Smith M T; Di Monte D A
PCR analysis of platelet mtDNA: lack of specific changes in Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 1993;8(1):74-82.
1993: Forno L S; DeLanney L E; Irwin I; Langston J W
Similarities and differences between MPTP-induced parkinsonsim and Parkinson's disease. Neuropathologic considerations.
Advances in neurology 1993;60():600-8.
1992: Widner H; Tetrud J; Rehncrona S; Snow B; Brundin P; Gustavii B; Björklund A; Lindvall O; Langston J W
Bilateral fetal mesencephalic grafting in two patients with parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)
The New England journal of medicine 1992;327(22):1556-63.
1992: Zweig R M; Singh A; Cardillo J E; Langston J W
The familial occurrence of Parkinson's disease. Lack of evidence for maternal inheritance.
Archives of neurology 1992;49(11):1205-7.
1992: Doty R L; Singh A; Tetrud J; Langston J W
Lack of major olfactory dysfunction in MPTP-induced parkinsonism.
Annals of neurology 1992;32(1):97-100.
1992: Wu E Y; Langston J W; Di Monte D A
Toxicity of the 1-methyl-4-phenyl-2,3-dihydropyridinium and 1-methyl-4-phenylpyridinium species in primary cultures of mouse astrocytes.
The Journal of pharmacology and experimental therapeutics 1992;262(1):225-30.
1992: Chan P; DeLanney L E; Irwin I; Langston J W; Di Monte D
MPTP-induced ATP loss in mouse brain.
Annals of the New York Academy of Sciences 1992;648():306-8.
1992: Di Monte D A; Wu E Y; Langston J W
Role of astrocytes in MPTP metabolism and toxicity.
Annals of the New York Academy of Sciences 1992;648():219-28.
1992: Gronemeyer S A; Langston J W; Hanna S L; Langston J W
MR imaging detection of calcified intracranial lesions and differentiation from iron-laden lesions.
Journal of magnetic resonance imaging : JMRI 1992;2(3):271-6.
1992: Gronemeyer S A; Langston J W; Hanna S L; Langston J W
MR imaging detection of calcified intracranial lesions and differentiation from iron-laden lesions.
Journal of magnetic resonance imaging : JMRI 1992;2(3):271-6.
1992: Tetrud J W; Langston J W
Protective and preventive therapeutic strategies: monoamine oxidase inhibitors.
Neurologic clinics 1992;10(2):541-52.
1992: Moratalla R; Quinn B; DeLanney L E; Irwin I; Langston J W; Graybiel A M
Differential vulnerability of primate caudate-putamen and striosome-matrix dopamine systems to the neurotoxic effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
Proceedings of the National Academy of Sciences of the United States of America 1992;89(9):3859-63.
1992: Di Monte D A; Wu E Y; Delanney L E; Irwin I; Langston J W
Toxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in primary cultures of mouse astrocytes.
The Journal of pharmacology and experimental therapeutics 1992;261(1):44-9.
1992: Tetrud J W; Langston J W
Tremor in MPTP-induced parkinsonism.
Neurology 1992;42(2):407-10.
1992: Kellie S J; Kovnar E H; Kun L E; Horowitz M E; Heideman R L; Douglass E C; Langston J W; Sanford R A; Jenkins J J; Fairclough D L
Neuraxis dissemination in pediatric brain tumors. Response to preirradiation chemotherapy.
Cancer 1992;69(4):1061-6.
1992: Irwin I; Finnegan K T; Delanney L E; Di Monte D; Langston J W
The relationships between aging, monoamine oxidase, striatal dopamine and the effects of MPTP in C57BL/6 mice: a critical reassessment.
Brain research 1992;572(1-2):224-31.
1992: Foreman N K; Mahmoud H H; Langston J W
99Tcm-HMPAO SPECT and magnetic resonance studies in L-asparaginase induced cerebrovascular accident.
The British journal of radiology 1992;65(769):78-81.
1992: Langston J W; Widner H; Goetz C G; Brooks D; Fahn S; Freeman T; Watts R
Core assessment program for intracerebral transplantations (CAPIT).
Movement disorders : official journal of the Movement Disorder Society 1992;7(1):2-13.
1992: Di Monte D A; Wu E Y; Irwin I; Delanney L E; Langston J W
Production and disposition of 1-methyl-4-phenylpyridinium in primary cultures of mouse astrocytes.
Glia 1992;5(1):48-55.
1992: Forno L S; DeLanney L E; Irwin I; Di Monte D; Langston J W
Astrocytes and Parkinson's disease.
Progress in brain research 1992;94():429-36.
1991: Kellie S J; Hayes F A; Bowman L; Kovnar E H; Langston J; Jenkins J J; Pao W J; Ducos R; Green A A
Primary extracranial neuroblastoma with central nervous system metastases characterization by clinicopathologic findings and neuroimaging.
Cancer 1991;68(9):1999-2006.
1991: Langston J W
[Search for the cause of Parkinson's disease]
Archivos de neurobiologiá 1991;54(6):264-71.
1991: Langston J W; Gronemeyer S A; Anderson S E; Hanna S L
Positioning platform for nonoblique total spine MR imaging.
AJNR. American journal of neuroradiology 1991;12(5):1001-2.
1991: Finnegan K T; Kerr J T; Langston J W
Dextromethorphan protects against the neurotoxic effects of p-chloroamphetamine in rats.
Brain research 1991;558(1):109-11.
1991: Di Monte D A; Wu E Y; Irwin I; Delanney L E; Langston J W
Biotransformation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in primary cultures of mouse astrocytes.
The Journal of pharmacology and experimental therapeutics 1991;258(2):594-600.
1991: Koller W C; Langston J W; Hubble J P; Irwin I; Zack M; Golbe L; Forno L; Ellenberg J; Kurland L; Ruttenber A J
Does a long preclinical period occur in Parkinson's disease?
Geriatrics 1991;46 Suppl 1():8-15.
1991: Langston J W; Koller W C
Preclinical detection of Parkinson's disease. The next frontier: presymptomatic detection. Introduction.
Geriatrics 1991;46 Suppl 1():5-7.
1991: Sebes J I; Langston J W; Gavant M L; Rothschild B
MR imaging of growth recovery lines in fossil vertebrae.
AJR. American journal of roentgenology 1991;157(2):415-6.
1991: Chan P; DeLanney L E; Irwin I; Langston J W; Di Monte D
Rapid ATP loss caused by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mouse brain.
Journal of neurochemistry 1991;57(1):348-51.
1991: Hanna S L; Langston J W; Gronemeyer S A
Value of subtraction images in the detection of hemorrhagic brain lesions on contrast-enhanced MR images.
AJNR. American journal of neuroradiology 1991;12(4):681-5.
1991: Koller W C; Langston J W; Hubble J P; Irwin I; Zack M; Golbe L; Forno L; Ellenberg J; Kurland L; Ruttenber A J
Does a long preclinical period occur in Parkinson's disease?
Neurology 1991;41(5 Suppl 2):8-13.
1991: Langston J W; Koller W C
The next frontier in Parkinson's disease: presymptomatic detection.
Neurology 1991;41(5 Suppl 2):5-7.
1991: Scotcher K P; Irwin I; DeLanney L E; Langston J W; Di Monte D
Mechanism of accumulation of the 1-methyl-4-phenylpyridinium species into mouse brain synaptosomes.
Journal of neurochemistry 1991;56(5):1602-7.
1991: Di Monte D; Tetrud J W; Langston J W
Blood lactate in Parkinson's disease.
Annals of neurology 1991;29(3):342-3.
1991: Wang W C; Kovnar E H; Tonkin I L; Mulhern R K; Langston J W; Day S W; Schell M J; Wilimas J A
High risk of recurrent stroke after discontinuance of five to twelve years of transfusion therapy in patients with sickle cell disease.
The Journal of pediatrics 1991;118(3):377-82.
1991: Forno L S; Langston J W
Unfavorable outcome of adrenal medullary transplant for Parkinson's disease.
Acta neuropathologica 1991;81(6):691-4.
1990: Kurth M C; Langston J W; Tetrud J W
"Stelazine" versus "selegiline"--a hazard in prescription writing.
The New England journal of medicine 1990;323(25):1776.
1990: Langston J W
Predicting Parkinson's disease.
Neurology 1990;40(10 Suppl 3):suppl 70-4; discussion 75-6.
1990: Tanner C M; Langston J W
Do environmental toxins cause Parkinson's disease? A critical review.
Neurology 1990;40(10 Suppl 3):suppl 17-30; discussion 30-1.
1990: Langston J W
Selegiline as neuroprotective therapy in Parkinson's disease: concepts and controversies.
Neurology 1990;40(10 Suppl 3):suppl 61-6; discussion 67-9.
1990: Irwin I; DeLanney L E; Forno L S; Finnegan K T; Di Monte D A; Langston J W
The evolution of nigrostriatal neurochemical changes in the MPTP-treated squirrel monkey.
Brain research 1990;531(1-2):242-52.
1990: Hanna S L; Lemmi M A; Langston J W; Fontanesi J; Brooks H L; Gronemeyer S
Treatment of choroidal melanoma: MR imaging in the assessment of radioactive plaque position.
Radiology 1990;176(3):851-3.
1990: Segal I S; Walton J K; Irwin I; DeLanney L E; Ricaurte G A; Langston J W; Maze M
Modulating role of dopamine on anesthetic requirements.
European journal of pharmacology 1990;186(1):9-15.
1990: Finnegan K T; Skratt J J; Irwin I; DeLanney L E; Langston J W
Protection against DSP-4-induced neurotoxicity by deprenyl is not related to its inhibition of MAO B.
European journal of pharmacology 1990;184(1):119-26.
1990: Bloem B R; Irwin I; Buruma O J; Haan J; Roos R A; Tetrud J W; Langston J W
The MPTP model: versatile contributions to the treatment of idiopathic Parkinson's disease.
Journal of the neurological sciences 1990;97(2-3):273-93.
1990: Golbe L I; Langston J W; Shoulson I
Selegiline and Parkinson's disease. Protective and symptomatic considerations.
Drugs 1990;39(5):646-51.
1990: Scotcher K P; Irwin I; DeLanney L E; Langston J W; Di Monte D
Effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and 1-methyl-4-phenylpyridinium ion on ATP levels of mouse brain synaptosomes.
Journal of neurochemistry 1990;54(4):1295-301.
1990: Stern Y; Tetrud J W; Martin W R; Kutner S J; Langston J W
Cognitive change following MPTP exposure.
Neurology 1990;40(2):261-4.
1990: Kovnar E H; Kellie S J; Horowitz M E; Sanford R A; Langston J W; Mulhern R K; Jenkins J J; Douglass E C; Etcubanas E E; Fairclough D L
Preirradiation cisplatin and etoposide in the treatment of high-risk medulloblastoma and other malignant embryonal tumors of the central nervous system: a phase II study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1990;8(2):330-6.
1990: Hanna S L; Langston J W; Gronemeyer S A; Fletcher B D
Subtraction technique for contrast-enhanced MR images of musculoskeletal tumors.
Magnetic resonance imaging 1990;8(3):213-5.
1990: Ricaurte G A; Finnegan K T; Irwin I; Langston J W
Aminergic metabolites in cerebrospinal fluid of humans previously exposed to MDMA: preliminary observations.
Annals of the New York Academy of Sciences 1990;600():699-708; discussion 708-10.
1989: Tetrud J W; Langston J W; Garbe P L; Ruttenber A J
Mild parkinsonism in persons exposed to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
Neurology 1989;39(11):1483-7.
1989: Finnegan K T; Skratt J J; Irwin I; Langston J W
The N-methyl-D-aspartate (NMDA) receptor antagonist, dextrorphan, prevents the neurotoxic effects of 3,4-methylenedioxymethamphetamine (MDMA) in rats.
Neuroscience letters 1989;105(3):300-6.
1989: Finnegan K T; DeLanney L E; Irwin I; Ricaurte G A; Langston J W
The amine-depleting effects of 5,7-dihydroxytryptamine (5,7-DHT) in C57BL/6 mice do not increase with age.
Brain research 1989;496(1-2):251-6.
1989: Tetrud J W; Langston J W
The effect of deprenyl (selegiline) on the natural history of Parkinson's disease.
Science (New York, N.Y.) 1989;245(4917):519-22.
1989: Di Monte D; Irwin I; Kupsch A; Cooper S; DeLanney L E; Langston J W
Diethyldithiocarbamate and disulfiram inhibit MPP+ and dopamine uptake by striatal synaptosomes.
European journal of pharmacology 1989;166(1):23-9.
1989: Irwin I; DeLanney L E; Di Monte D; Langston J W
The biodisposition of MPP+ in mouse brain.
Neuroscience letters 1989;101(1):83-8.
1989: Ricaurte G A; DeLanney L E; Irwin I; Witkin J M; Katz J L; Langston J W
Evaluation of the neurotoxic potential of N,N-dimethylamphetamine: an illicit analog of methamphetamine.
Brain research 1989;490(2):301-6.
1989: Langston J W
Current theories on the cause of Parkinson's disease.
Journal of neurology, neurosurgery, and psychiatry 1989;Suppl():13-7.
1989: Tetrud J W; Langston J W
MPTP-induced parkinsonism as a model for Parkinson's disease.
Acta neurologica Scandinavica. Supplementum 1989;126():35-40.
1989: Langston J W
Mechanisms underlying neuronal degeneration in Parkinson's disease: an experimental and theoretical treatise.
Movement disorders : official journal of the Movement Disorder Society 1989;4 Suppl 1():S15-25.
1988: Ricaurte G A; DeLanney L E; Wiener S G; Irwin I; Langston J W
5-Hydroxyindoleacetic acid in cerebrospinal fluid reflects serotonergic damage induced by 3,4-methylenedioxymethamphetamine in CNS of non-human primates.
Brain research 1988;474(2):359-63.
1988: Langston J W
Neuromelanin-containing neurons are selectively vulnerable in parkinsonism.
Trends in pharmacological sciences 1988;9(10):347-8.
1988: Notter M F; Irwin I; Langston J W; Gash D M
Neurotoxicity of MPTP and MPP+ in vitro: characterization using specific cell lines.
Brain research 1988;456(2):254-62.
1988: Ricaurte G A; Forno L S; Wilson M A; DeLanney L E; Irwin I; Molliver M E; Langston J W
(+/-)3,4-Methylenedioxymethamphetamine selectively damages central serotonergic neurons in nonhuman primates.
JAMA : the journal of the American Medical Association 1988;260(1):51-5.
1988: Forno L S; Langston J W; DeLanney L E; Irwin I
An electron microscopic study of MPTP-induced inclusion bodies in an old monkey.
Brain research 1988;448(1):150-7.
1988: Irwin I; Ricaurte G A; DeLanney L E; Langston J W
The sensitivity of nigrostriatal dopamine neurons to MPP+ does not increase with age.
Neuroscience letters 1988;87(1-2):51-6.
1988: Finnegan K T; Ricaurte G A; Ritchie L D; Irwin I; Peroutka S J; Langston J W
Orally administered MDMA causes a long-term depletion of serotonin in rat brain.
Brain research 1988;447(1):141-4.
1988: Ricaurte G A; DeLanney L E; Irwin I; Langston J W
Toxic effects of MDMA on central serotonergic neurons in the primate: importance of route and frequency of drug administration.
Brain research 1988;446(1):165-8.
1988: Horowitz M E; Kun L E; Mulhern R K; Kovnar E H; Sanford R A; Hockenberger B M; Greeson F L; Langston J W; Fairclough D L; Jenkins J J
Feasibility and efficacy of preirradiation chemotherapy for pediatric brain tumors.
Neurosurgery 1988;22(4):687-90.
1988: Ricaurte G A; DeLanney L E; Finnegan K T; Irwin I; Langston J W
The dopamine-depleting effect of 6-hydroxydopamine does not increase with aging.
Brain research 1988;438(1-2):395-8.
1988: Beresford T P; Blow F C; Hall R C; Nichols L O; Langston J W
CT scanning in psychiatric inpatients: II. Clinical data predicting scan results.
Psychosomatics 1988;29(3):321-7.
1987: Kiernan R J; Mueller J; Langston J W; Van Dyke C
The Neurobehavioral Cognitive Status Examination: a brief but quantitative approach to cognitive assessment.
Annals of internal medicine 1987;107(4):481-5.
1987: Finnegan K T; Irwin I; Delanney L E; Ricaurte G A; Langston J W
1,2,3,6-tetrahydro-1-methyl-4-(methylpyrrol-2-yl)pyridine: studies on the mechanism of action of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
The Journal of pharmacology and experimental therapeutics 1987;242(3):1144-51.
1987: Irwin I; Wu E Y; DeLanney L E; Trevor A; Langston J W
The effect of diethyldithiocarbamate on the biodisposition of MPTP: an explanation for enhanced neurotoxicity.
European journal of pharmacology 1987;141(2):209-17.
1987: Ricaurte G A; Finnegan K F; Nichols D E; DeLanney L E; Irwin I; Langston J W
3,4-Methylenedioxyethylamphetamine (MDE), a novel analogue of MDMA, produces long-lasting depletion of serotonin in the rat brain.
European journal of pharmacology 1987;137(2-3):265-8.
1987: Ransom B R; Kunis D M; Irwin I; Langston J W
Astrocytes convert the parkinsonism inducing neurotoxin, MPTP, to its active metabolite, MPP+.
Neuroscience letters 1987;75(3):323-8.
1987: Langston J W
Parkinson's disease: current view.
American family physician 1987;35(3):201-6.
1987: Ricaurte G A; Irwin I; Forno L S; DeLanney L E; Langston E; Langston J W
Aging and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced degeneration of dopaminergic neurons in the substantia nigra.
Brain research 1987;403(1):43-51.
1987: Langston J W; Irwin I; DeLanney L E
The biotransformation of MPTP and disposition of MPP+: the effects of aging.
Life sciences 1987;40(8):749-54.
1987: Irwin I; Langston J W; DeLanney L E
4-Phenylpyridine (4PP) and MPTP: the relationship between striatal MPP+ concentrations and neurotoxicity.
Life sciences 1987;40(8):731-40.
1987: Ricaurte G A; DeLanney L E; Irwin I; Langston J W
Older dopaminergic neurons do not recover from the effects of MPTP.
Neuropharmacology 1987;26(1):97-9.
1987: Langston J W
MPTP: insights into the etiology of Parkinson's disease.
European neurology 1987;26 Suppl 1():2-10.
1987: Langston J W; Irwin I; Ricaurte G A
Neurotoxins, parkinsonism and Parkinson's disease.
Pharmacology & therapeutics 1987;32(1):19-49.
1987: Tetrud J W; Langston J W
R-(-)-deprenyl as a possible protective agent in Parkinson's disease.
Journal of neural transmission. Supplementum 1987;25():69-79.
1986: Hotson J R; Langston E B; Langston J W
Saccade responses to dopamine in human MPTP-induced parkinsonism.
Annals of neurology 1986;20(4):456-63.
1986: Forno L S; Langston J W; DeLanney L E; Irwin I; Ricaurte G A
Locus ceruleus lesions and eosinophilic inclusions in MPTP-treated monkeys.
Annals of neurology 1986;20(4):449-55.
1986: Ricaurte G A; Langston J W; Delanney L E; Irwin I; Peroutka S J; Forno L S
Fate of nigrostriatal neurons in young mature mice given 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: a neurochemical and morphological reassessment.
Brain research 1986;376(1):117-24.
1986: Beresford T P; Blow F C; Hall R C; Nichols L O; Langston J W
CT scanning in psychiatric inpatients: clinical yield.
Psychosomatics 1986;27(2):105-12.
1986: Langston J W; Irwin I
MPTP: current concepts and controversies.
Clinical neuropharmacology 1986;9(6):485-507.
1985: Stern Y; Langston J W
Intellectual changes in patients with MPTP-induced parkinsonism.
Neurology 1985;35(10):1506-9.
1985: Ricaurte G A; Langston J W; DeLanney L E; Irwin I; Brooks J D
Dopamine uptake blockers protect against the dopamine depleting effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the mouse striatum.
Neuroscience letters 1985;59(3):259-64.
1985: Calne D B; Langston J W; Martin W R; Stoessl A J; Ruth T J; Adam M J; Pate B D; Schulzer M
Positron emission tomography after MPTP: observations relating to the cause of Parkinson's disease.
Nature 1985;317(6034):246-8.
1985: Beresford T P; Blow F C; Nichols L O; Langston J W; Hall R C
Focal signs and brain CT scan in psychiatric patients.
The New England journal of medicine 1985;313(6):388.
1985: Langston J W; Gavant M L
"Incomplete ring" sign: a simple method for CT detection of spondylolysis.
Journal of computer assisted tomography 1985;9(4):728-9.
1985: Ballard P A; Tetrud J W; Langston J W
Permanent human parkinsonism due to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): seven cases.
Neurology 1985;35(7):949-56.
1985: Peroutka S J; DeLanney L; Irwin I; Ison P J; Ricaurte G; Schlegel J R; Langston J W
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) induced dopamine D2 receptor hypersensitivity in the mouse is transient.
Research communications in chemical pathology and pharmacology 1985;48(2):163-71.
1985: Irwin I; Langston J W
Safety and handling of MPTP.
Neurology 1985;35(4):619.
1985: Barbeau A; Dallaire L; Buu N T; Veilleux F; Boyer H; de Lanney L E; Irwin I; Langston E B; Langston J W
New amphibian models for the study of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
Life sciences 1985;36(11):1125-34.
1985: Barbeau A; Roy M; Langston J W
Neurological consequence of industrial exposure to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
Lancet 1985;1(8431):747.
1985: Irwin I; Langston J W
Selective accumulation of MPP+ in the substantia nigra: a key to neurotoxicity?
Life sciences 1985;36(3):207-12.
1985: Langston J W
MPTP neurotoxicity: an overview and characterization of phases of toxicity.
Life sciences 1985;36(3):201-6.
1984: Langston J W; Irwin I; Langston E B; Forno L S
The importance of the '4-5' double bond for neurotoxicity in primates of the pyridine derivative MPTP.
Neuroscience letters 1984;50(1-3):289-94.
1984: Langston J W; Irwin I; Langston E B; Forno L S
Pargyline prevents MPTP-induced parkinsonism in primates.
Science (New York, N.Y.) 1984;225(4669):1480-2.
1984: Langston J W; Irwin I; Langston E B; Forno L S
1-Methyl-4-phenylpyridinium ion (MPP+): identification of a metabolite of MPTP, a toxin selective to the substantia nigra.
Neuroscience letters 1984;48(1):87-92.
1984: Langston J W; Ballard P
Parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): implications for treatment and the pathogenesis of Parkinson's disease.
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 1984;11(1 Suppl):160-5.
1984: Langston J W; Forno L S; Rebert C S; Irwin I
Selective nigral toxicity after systemic administration of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyrine (MPTP) in the squirrel monkey.
Brain research 1984;292(2):390-4.
1984: Langston J W; Langston E B; Irwin I
MPTP-induced parkinsonism in human and non-human primates--clinical and experimental aspects.
Acta neurologica Scandinavica. Supplementum 1984;100():49-54.
1983: Calne D B; Langston J W
Aetiology of Parkinson's disease.
Lancet 1983;2(8365-66):1457-9.
1983: Langston J W; Ballard P A
Parkinson's disease in a chemist working with 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine.
The New England journal of medicine 1983;309(5):310.
1983: Apte S N; Langston J W
Permanent neurological deficits due to lithium toxicity.
Annals of neurology 1983;13(4):453-5.
1983: Langston J W; Ballard P; Tetrud J W; Irwin I
Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis.
Science (New York, N.Y.) 1983;219(4587):979-80.
1983: Mueller J; Hotson J R; Langston J W
Hyperviscosity-induced dementia.
Neurology 1983;33(1):101-3.
1980: Carnevale N T; Galgiani J N; Stevens D A; Herrick M K; Langston J W
Amphotericin B-induced myelopathy.
Archives of internal medicine 1980;140(9):1189-92.
1980: Gerald B; Sebes J I; Langston J W
Cerebral infarction secondary to sickle cell disease: arteriographic findings.
AJR. American journal of roentgenology 1980;134(6):1209-12.
1980: Wilimas J; Goff J R; Anderson H R; Langston J W; Thompson E
Efficacy of transfusion therapy for one to two years in patients with sickle cell disease and cerebrovascular accidents.
The Journal of pediatrics 1980;96(2):205-8.
1979: Culberson C G; Langston J W; Herrick M
Aminophylline encephalopathy: a clinical, electroencephalographic, and neuropathological analysis.
Transactions of the American Neurological Association 1979;104():224-6.
1978: Langston J W; Forno L S
The hypothalamus in Parkinson disease.
Annals of neurology 1978;3(2):129-33.
1977: White J C; Langston J W; Pedley T A
Benign epileptiform transients of sleep. Clarification of the small sharp spike controversy.
Neurology 1977;27(11):1061-8.
1977: Langston J W; Ricci D R; Portlock C
Nonhypoxemic hazards of prolonged myoclonus.
Neurology 1977;27(6):542-5.
1977: Feldon S E; Langston J W
Square-wave jerks: a disorder of microsaccades?
Neurology 1977;27(3):278-81.
1976: Langston J W; Tharp B R
Infantile hemifacial spasm.
Archives of neurology 1976;33(4):302-3.
1976: Leonard S A; Silverman A J; Langston J W; Fuselier H A
Postoperative nephrogenic adenoma of bladder.
Urology 1976;7(3):327-8.
1976: Hotson J R; Langston J W
Disulfiram-induced encephalopathy.
Archives of neurology 1976;33(2):141-2.
1976: Baker R A; Rosenbaum A E; Langston J W
Xeroradiography. Its value in gas myelography.
Acta radiologica. Supplementum 1976;347():423-9.
1975: Langston J W; Dorfman L J; Forno L S
"Encephalomyeloneuritis" in the absence of cancer.
Neurology 1975;25(7):633-7.
1975: Schober R; Langston J W; Forno L S
Idiopathic orthostatic hypotension. Biochemical and pathologic observations in 2 cases.
European neurology 1975;13(3):177-88.
1974: Phillips J C; Easterly J F; Langston J W
Contrast enhancement of pelvo-abdominal masses: the rim sign.
Radiology 1974;112(1):17-21.
1968: Fisher J W; Langston J W
Effects of testosterone, cobalt and hypoxia on erythropoietin production in the isolated perfused dog kidney.
Annals of the New York Academy of Sciences 1968;149(1):75-87.
1967: Fisher J W; Samuels A I; Langston J W
Effects of angiotensin and renal artery constriction on erythropoietin production.
The Journal of pharmacology and experimental therapeutics 1967;157(3):618-25.
1967: Fisher J W; Langston J W
The influence of hypoxemia and cobalt on erythropoietin production in the isolated perfused dog kidney.
Blood 1967;29(1):114-25.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

William Langston

Research Profile (preview)

Chemicals & Drugs

Disorders

Anatomy

Living Beings

Concepts & Ideas

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of William Langston (preview)

All Publications